Recurrent metastatic melanoma
Showing 1 - 25 of >10,000
Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)
Not yet recruiting
- Recurrent Metastatic Melanoma
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 29, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +3 more
- Anti-PD-L1 Monoclonal Antibody IMC-001
- Punch Biopsy
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Newly Diagnosed or Recurrent Metastatic Melanoma Patients, Malignant Brain Tumors Trial in New York (PET scan with
Active, not recruiting
- Newly Diagnosed or Recurrent Metastatic Melanoma Patients
- Malignant Brain Tumors
- PET scan with 124I-cRGDY-PEG-dots
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 13, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Aerosol Sargramostim
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Recruiting
- Brain Metastases
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Bevacizumab Injection
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)
Terminated
- Unresectable, Recurrent or Metastatic Melanoma
- Untreated Mucosal or Acral Lentiginous Melanoma
-
Beijing, Beijing, China
- +12 more
Apr 12, 2022
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Ibrutinib
- +3 more
-
Los Angeles, California
- +12 more
Jul 27, 2022
SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)
Not yet recruiting
- SCLC
- +2 more
- GD2-SADA:177Lu-DOTA Complex
- (no location specified)
May 4, 2022
Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)
Recruiting
- Locally Advanced Unresectable or Metastatic Melanoma
-
Los Angeles, California
- +12 more
Jun 30, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Melanoma Trial in United Kingdom (ATL001, Checkpoint Inhibitor)
Recruiting
- Melanoma
- ATL001
- Checkpoint Inhibitor
-
Cambridge, United Kingdom
- +6 more
Jul 23, 2021
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10
Not yet recruiting
- Advanced Glioblastoma
- +2 more
- Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
- Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
-
Ramat Gan, IsraelSheba medical center
Jun 11, 2023
Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)
Recruiting
- Unresectable Melanoma
- +3 more
- IOV-4001
-
Louisville, Kentucky
- +2 more
Nov 21, 2022
Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)
Active, not recruiting
- Tumor Skin
- +2 more
- OBX-115
-
Orlando, Florida
- +1 more
Sep 28, 2023
